Terme Catez, d.d. (LJSE:TCRG)
65.00
0.00 (0.00%)
At close: Jun 19, 2026
Terme Catez, d.d. Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 39.33 | 36.87 | 33.68 | 31.76 | 25.39 |
| 39.33 | 36.87 | 33.68 | 31.76 | 25.39 | |
Revenue Growth (YoY) | 6.69% | 9.45% | 6.06% | 25.09% | 35.97% |
Cost of Revenue | 30.7 | 28.66 | 28.43 | 26.07 | 19.63 |
Gross Profit | 8.63 | 8.2 | 5.25 | 5.69 | 5.76 |
Other Operating Expenses | 0.15 | 0.54 | -0.39 | -0.49 | -0.89 |
Operating Expenses | 4.32 | 4.56 | 3.55 | 3.51 | 3.34 |
Operating Income | 4.31 | 3.64 | 1.7 | 2.18 | 2.42 |
Interest Expense | -1.19 | -1.65 | -1.9 | -1.25 | -1.53 |
Interest & Investment Income | 0.2 | 0.11 | 0.09 | 0.1 | 7.61 |
Currency Exchange Gain (Loss) | - | - | - | - | 0 |
Other Non Operating Income (Expenses) | 0.11 | 0.83 | 0.55 | 0.18 | 0.21 |
EBT Excluding Unusual Items | 3.43 | 2.93 | 0.44 | 1.21 | 8.71 |
Gain (Loss) on Sale of Investments | -0.58 | - | - | -0 | -0 |
Gain (Loss) on Sale of Assets | - | 0.68 | 1.94 | 0.02 | 0.05 |
Asset Writedown | -0.03 | -0 | -0 | -0.01 | -0.48 |
Other Unusual Items | - | - | - | - | 0 |
Pretax Income | 2.82 | 3.61 | 2.38 | 1.22 | 8.28 |
Income Tax Expense | 0.93 | 1.07 | 0.3 | 0.23 | 0.69 |
Earnings From Continuing Operations | 1.89 | 2.54 | 2.08 | 0.99 | 7.6 |
Earnings From Discontinued Operations | - | - | - | - | 0.28 |
Net Income to Company | 1.89 | 2.54 | 2.08 | 0.99 | 7.88 |
Net Income | 1.89 | 2.54 | 2.08 | 0.99 | 7.88 |
Net Income to Common | 1.89 | 2.54 | 2.08 | 0.99 | 7.88 |
Net Income Growth | -25.56% | 22.18% | 111.19% | -87.48% | - |
Shares Outstanding (Basic) | 0 | 0 | 0 | 0 | 0 |
Shares Outstanding (Diluted) | 0 | 0 | 0 | 0 | 0 |
EPS (Basic) | 3.86 | 5.19 | 4.25 | 2.01 | 16.07 |
EPS (Diluted) | 3.86 | 5.19 | 4.25 | 2.01 | 16.07 |
EPS Growth | -25.56% | 22.18% | 111.19% | -87.48% | - |
Free Cash Flow | 3.65 | -3.82 | 3.98 | 1.93 | 1.63 |
Free Cash Flow Per Share | 7.44 | -7.80 | 8.12 | 3.95 | 3.33 |
Dividend Per Share | - | 1.010 | 0.500 | - | - |
Dividend Growth | - | 102.00% | - | - | - |
Gross Margin | 21.95% | 22.25% | 15.58% | 17.91% | 22.67% |
Operating Margin | 10.96% | 9.88% | 5.05% | 6.86% | 9.53% |
Profit Margin | 4.81% | 6.90% | 6.18% | 3.10% | 31.02% |
Free Cash Flow Margin | 9.27% | -10.37% | 11.81% | 6.09% | 6.42% |
EBITDA | 8.36 | 7.66 | 5.63 | 6.18 | 6.63 |
EBITDA Margin | 21.25% | 20.77% | 16.73% | 19.45% | 26.13% |
D&A For EBITDA | 4.05 | 4.01 | 3.93 | 4 | 4.21 |
EBIT | 4.31 | 3.64 | 1.7 | 2.18 | 2.42 |
EBIT Margin | 10.96% | 9.88% | 5.05% | 6.86% | 9.53% |
Effective Tax Rate | 32.82% | 29.60% | 12.63% | 18.93% | 8.29% |